acetylcysteine has been researched along with Gout in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabezas, R; Elsaid, KA; ElSayed, S; Jay, GD; Qadri, M; Schmidt, TA | 1 |
| Alberts, BM; Basnayake, K; Bruce, C; Davies, KA; Ghezzi, P; Mullen, LM | 1 |
2 other study(ies) available for acetylcysteine and Gout
| Article | Year |
|---|---|
Recombinant Human Proteoglycan 4 Regulates Phagocytic Activation of Monocytes and Reduces IL-1β Secretion by Urate Crystal Stimulated Gout PBMCs.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Female; Free Radical Scavengers; Gout; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Leukocytes, Mononuclear; Male; Mice; Mice, Knockout; Middle Aged; Neutrophils; Phagocytosis; Protein Phosphatase 2; Proteoglycans; Reactive Oxygen Species; Recombinant Proteins; THP-1 Cells; Uric Acid | 2021 |
Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
Topics: Acetylcysteine; Antioxidants; Cell Survival; Furans; Gene Expression; Gout; Heterocyclic Compounds, 4 or More Rings; Humans; Hyperuricemia; Indenes; Inflammasomes; Interleukin-1beta; Lipopeptides; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic; Sulfonamides; Sulfones; Superoxide Dismutase; Thioredoxin Reductase 1; Toll-Like Receptor 2; Uric Acid | 2019 |